Revelation Biosciences Warrant
REVBW
12 hedge funds and large institutions have $30K invested in Revelation Biosciences Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.
26.78% more ownership
Funds ownership: 8.62% → 35.4% (+27%)
10% less capital invested
Capital invested by funds: $33.4K → $30K (-$3.4K)
29% less funds holding
Funds holding: 17 → 12 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$2.77K |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.62K |
| 3 |
Jane Street
New York
|
-$553 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$97 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$44 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $12.8K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $4.39K | – | – | – |
|
3
Walleye Capital
New York
| $3.33K | – | – | – |
|
4
Walleye Trading
New York
| $1.87K | – | – | – |
|
|
CAC
5
Cowen and Company
New York
| $1.75K | – | – | – |
|
|
AC
6
Ayrton Capital
Westport,
Connecticut
| $1.33K | – | – | – |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $1.32K | – | – | – |
|
|
8
Jane Street
New York
| $890 | -$553 | -30,746 | -38% |
|
|
PFM
9
Privium Fund Management
Amsterdam,
Netherlands
| $880 | – | – | – |
|
|
PVI
10
Pine Valley Investments
Marlton,
New Jersey
| $781 | – | – | – |
|
|
EPM
11
Equitec Proprietary Markets
Chicago,
Illinois
| $356 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| $294 | -$44 | -2,419 | -14% |
|
|
ICM
13
Ionic Capital Management
New York
| – | -$2.77K | -171,189 | Closed |
|
|
BRF
14
B. Riley Financial
Los Angeles,
California
| – | -$1.62K | -100,000 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$97 | -6,089 | Closed |
|
REVBW Hedge Fund Activity: Q2 2023 in Review
12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2023, worth a combined $30K — down 10% from $33.4K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of REVBW and 0 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Ionic Capital Management, exiting entirely with an estimated $2.77K sold.
- 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2023, down from 17 in Q1 2023.
- Funds reported $30K of Revelation Biosciences Warrant stock for Q2 2023, down 10% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences Warrant positions in Q2 2023 and 5 closed out, a net change of -5 holders.
- The largest Revelation Biosciences Warrant seller in Q2 2023 was Ionic Capital Management, an estimated $2.77K sold.
Based on aggregated 13F filings for Q2 2023.